Developing a quantitative external quality assurance (EQA) module to monitor BCR-ABL1 levels in chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL) using the international scale (IS) to determine a patient's molecular response

Pathology ◽  
2018 ◽  
Vol 50 ◽  
pp. S100-S101
Author(s):  
Nalishia Pillay ◽  
Martin Horan ◽  
Sze Yee Chai ◽  
Tony Badrick ◽  
Susan Branford ◽  
...  
Keyword(s):  
Quality Assurance ◽  
Chronic Myeloid Leukaemia ◽  
Acute Lymphoblastic Leukaemia ◽  
Myeloid Leukaemia ◽  
Lymphoblastic Leukaemia ◽  
External Quality Assurance ◽  
Molecular Response ◽  
External Quality ◽  
International Scale

Paediatric malignancies

2011 ◽  
Author(s):  
Thankamma Ajithkumar ◽  
Ann Barrett ◽  
Helen Hatcher ◽  
Natalie Cook
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Chronic Myeloid Leukaemia ◽  
Acute Myeloid Leukaemia ◽  
Acute Lymphoblastic Leukaemia ◽  
Myeloid Leukaemia ◽  
Lymphoblastic Leukaemia ◽  
Bone Marrow Failure ◽  
Clonal Proliferation ◽  
Acute Myeloid

Leukaemia is the commonest cancer (accounting for >40% of cases) in children. It is a clonal proliferation of stem cells which leads to bone marrow failure and tissue infiltration.• Acute lymphoblastic leukaemia (ALL): 4/100,000• Acute myeloid leukaemia (AML): 0.7/100,000• Chronic myeloid leukaemia (CML): 0.2/100,000...

Sign in / Sign up

Export Citation Format

Share Document